WHO ICTRP trial

Efficacy and safety of dapnetin capsules in the treatment of patients with…

ChiCTR2500095975 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500095975
Public title Efficacy and safety of dapnetin capsules in the treatment of patients with simple varicose veins of the lower extremities combined with superficial thrombophlebitis - a prospective, multicenter, randomized controlled study
Scientific title Efficacy and safety of dapnetin capsules in the treatment of patients with simple varicose veins of the lower extremities combined with superficial thrombophlebitis - a prospective, multicenter, randomized controlled study - Efficacy and safety of dapnetin capsules in the treatment of simple…
Primary sponsor The Second Affiliated Hospital of Xi 'an Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 4
Countries China
Conditions Simple varicose veins of lower extremity with superficial thrombophlebitis
Interventions control group:conventional medical treatment as described in the guidelines. ;experimental group:conventional medical treatment with oral dapnetin capsules. 0.15g/ pill, 0.45g/ time, 3 times/day for 12 weeks.
Registration date Jan 15, 2025
Target size control group:120;experimental group:120
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations